U.S. Software Stock News

NasdaqGS:QS
NasdaqGS:QSAuto Components

Why QuantumScape (QS) Is Up 11.7% After Eagle Line Launch And First Ecosystem Billings

QuantumScape recently completed installation and start-up of its Eagle Line pilot-scale solid-state cell production facility, reported its first US$11,000,000 in customer billings from ecosystem partners, and delivered a narrower GAAP net loss for Q1 2026 driven by lower operating expenses. This progress marks a shift from pure development toward early commercialization, including an emerging licensing and royalty stream that may reshape how investors view QuantumScape’s business model and...
NasdaqGM:AGNT
NasdaqGM:AGNTReal Estate

AGNT Rebrands eXp With NextHome Acquisition And Multi Model Upside

eXp World Holdings, now trading under the ticker NasdaqGM:AGNT, has acquired franchise based brokerage NextHome. The company is shifting to a multi model real estate platform that offers both cloud brokerage and franchise options for agents and brokers. The new structure brings multiple brands under one global umbrella, with the AGNT ticker reflecting the broader platform focus. For real estate investors, NasdaqGM:AGNT now represents more than a pure cloud brokerage business. The...
NYSE:PEG
NYSE:PEGIntegrated Utilities

Strong Q1 Earnings And Grid Investment Plan Could Be A Game Changer For Public Service Enterprise Group (PEG)

Public Service Enterprise Group Incorporated has already reported first-quarter 2026 results, with sales rising to US$3,848 million and net income to US$741 million, lifting basic and diluted earnings per share from continuing operations to US$1.48. The company also declared a quarterly dividend of US$0.67 per share and reaffirmed its full-year earnings guidance alongside a multi‑year regulated capital investment plan, underscoring the role of extreme winter-driven demand and ongoing grid...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Moderna Hantavirus Program Draws New Focus As Shares Outpace Targets

Moderna (NasdaqGS:MRNA) is developing an early-stage mRNA vaccine candidate targeting hantavirus. Interest in the program has increased following a recent hantavirus outbreak linked to a cruise ship. The company is working with partners including the US Army Medical Research Institute of Infectious Diseases and Korea University. For investors tracking Moderna beyond its COVID-19 franchise, the renewed focus on its hantavirus program adds another data point to the broader mRNA story. The...
NYSE:VNO
NYSE:VNOOffice REITs

What Vornado Realty Trust (VNO)'s Park Avenue Plaza Deal and Buybacks Mean For Shareholders

Vornado Realty Trust recently reported first-quarter 2026 results showing revenue of US$459.11 million and a net loss of US$7.32 million, while also authorizing a new US$300 million share repurchase program, declaring quarterly preferred dividends, and agreeing to acquire a 49% interest in Park Avenue Plaza in Manhattan. The Park Avenue Plaza acquisition at a US$1.10 billion gross asset valuation, alongside continued buybacks and portfolio repositioning, underscores Vornado’s focus on...
NYSE:SDRL
NYSE:SDRLEnergy Services

How Raised 2026 Revenue Guidance and New Contracts At Seadrill (SDRL) Has Changed Its Investment Story

In the past week, Seadrill Limited reported first-quarter 2026 results showing revenue of US$358 million, sales of US$285 million, and a narrowed net loss of US$7 million, while also lifting its full-year 2026 total operating revenue guidance to US$1.43 billion–US$1.48 billion. The company also highlighted more than US$860 million of new contract awards across key offshore basins and timely completion of major projects, which together point to a growing contract backlog and improving...
NYSE:PHIN
NYSE:PHINAuto Components

PHINIA (PHIN) Is Up 8.1% After Debuting Hydrogen Van And Boosting Capital Returns - Has The Bull Case Changed?

In early May 2026, PHINIA Inc. showcased its first homologated hydrogen internal combustion engine light commercial vehicle at ACT Expo in Las Vegas, highlighting lower-carbon technology developed with Aramco that meets Euro 7 standards and targets very large reductions in tailpipe CO2 emissions versus diesel. The company coupled this technology milestone with a solid first-quarter earnings report, higher year-on-year sales and net income, continued 2026 guidance, and completion of a...
NYSE:SPH
NYSE:SPHGas Utilities

Suburban Propane Partners (SPH) Valuation Check After Q2 Earnings And Renewable Gas Expansion

Suburban Propane Partners (SPH) has drawn fresh attention after reporting second quarter fiscal 2026 earnings, with net income holding near last year despite lower revenue and continued progress in renewable natural gas projects. See our latest analysis for Suburban Propane Partners. Suburban Propane Partners’ share price has been relatively steady over recent months. The current price of $19.61 sits alongside a year to date share price return of 4.92%, while longer term total shareholder...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

A Look At Hepsiburada (HEPS) Valuation After Growth-Focused Earnings And Wider Net Loss

D-Market Elektronik Hizmetler ve Ticaret (HEPS) is back on investors’ radar after reporting first quarter 2026 results, with higher sales and gross merchandise value alongside a wider net loss driven by growth investments. See our latest analysis for D-Market Elektronik Hizmetler ve Ticaret. The earnings release appears to have cooled very short term sentiment, with the share price down 2.48% over the last day and 1.43% over the week. However, a 7.42% year to date share price return contrasts...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Assessing Bruker (BRKR) Valuation After A Recent Share Price Rebound

What Bruker’s recent performance means for investors Bruker (BRKR) has drawn attention after a mixed stretch for the stock, with a gain of about 19% over the past week and an increase of roughly 15% over the past month. See our latest analysis for Bruker. That recent burst of momentum, with an 18.9% 7 day share price return and a 15.1% 30 day share price return to US$43.27, contrasts with a softer year to date share price return and a 3 year total shareholder return that has been weak. As a...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

Assessing DraftKings (DKNG) Valuation After Profitability Milestone And Prediction Markets Expansion

DraftKings (DKNG) drew fresh attention after reporting first quarter 2026 results that combined higher sales, a move into profitability, and a larger push into prediction markets, which is setting up new questions for investors. See our latest analysis for DraftKings. The earnings surprise has come against a mixed share price backdrop, with the stock at US$24.51 after a 1 month share price return of 10.26%, yet a year to date share price return that is down 31.27% and a 1 year total...
NYSE:WLK
NYSE:WLKChemicals

Westlake (WLK) Valuation Check As Shares Rebound After Recent Pullback

Why Westlake Stock Is Drawing Attention Now Westlake (WLK) is back on investors’ radar after recent share price swings, with the stock up about 4% over the past day but down roughly 18% over the past month. See our latest analysis for Westlake. The recent 1-day share price return of 3.95% comes after a tougher stretch, with the 30-day share price return down 17.58% even as the year-to-date share price return is 31.57% and the 1-year total shareholder return is 16.98%. This points to fading...
NYSE:KBH
NYSE:KBHConsumer Durables

KB Home (KBH) Valuation Check After Revenue Miss And Softer Investor Sentiment

KB Home (KBH) stock is in focus after its latest quarterly update showed revenue down 22.6% year on year and below analyst expectations, which has weighed on sentiment, even though management pointed to a larger community count next quarter. See our latest analysis for KB Home. The weaker quarter and recent executive changes have coincided with softer momentum. The share price is at $47.87 after falling 24.63% over 90 days, while the 5 year total shareholder return of 12.92% points to a more...
NYSE:LVS
NYSE:LVSHospitality

Do Las Vegas Sands’ New Fixed-Rate Notes Reveal a Shifting Funding Strategy for LVS?

In early May 2026, Las Vegas Sands Corp. completed two fixed-rate, callable senior unsecured note offerings totaling about US$998.30 million, with coupons of 5.30% due 2031 and 5.65% due 2033, alongside additions of BNP Paribas, Scotia Capital and Morgan Stanley as co-lead underwriters. While these bond issues refine Las Vegas Sands' funding mix, investor attention remains heavily influenced by ongoing Macau revenue pressures and related sentiment. Next, we'll examine how these new...
NYSE:OMF
NYSE:OMFConsumer Finance

Did Higher Q1 Earnings and Completed Buyback Just Shift OneMain Holdings' (OMF) Investment Narrative?

In early May 2026, OneMain Holdings reported first-quarter 2026 net income of US$226 million versus US$213 million a year earlier, completed a buyback of 2,308,900 shares for US$141.58 million, and affirmed a quarterly dividend of US$1.05 per share payable on May 15, 2026. Together, the higher quarterly net income, completed repurchase of nearly 2% of shares, and continued cash dividend underline the company’s focus on returning capital while maintaining earnings strength. We’ll now examine...
NYSE:IDT
NYSE:IDTTelecom

Assessing IDT (IDT) Valuation After Strong April NRSInsights Same Store Sales Data

NRSInsights data on April same-store sales and transaction values has put a spotlight on IDT (IDT), as investors weigh how this retail activity feeds into the company’s broader communications and fintech operations. See our latest analysis for IDT. At a share price of $52.16, IDT has a 30 day share price return of 5.01% and a 90 day share price return of 6.38%, while the 1 year total shareholder return is down 9.36% and the 5 year total shareholder return is up 103.87%. This indicates that...
NYSE:TEX
NYSE:TEXMachinery

Terex (TEX): Do Rising Sales And Fresh Losses Reveal A Shift In Its Capital Priorities?

In May 2026, Terex Corporation reported first-quarter 2026 results showing sales of US$1,734 million, up from US$1,229 million a year earlier, but a net loss of US$89 million versus prior net income of US$21 million, alongside no share repurchases under its July 2025 authorization and completion of a US$117.16 million buyback launched in December 2022. This combination of stronger revenues with a shift to loss-making operations, plus a pause on the newer repurchase plan, raises fresh...
NYSE:HRB
NYSE:HRBConsumer Services

A Look At H&R Block’s (HRB) Valuation After Strong Q3 Earnings Outlook Upgrade And AI Adoption

H&R Block (HRB) has jumped back into focus after third quarter earnings, with higher revenue and net income supported by a tax benefit and buybacks, a raised 2026 outlook, and ongoing dividend support. See our latest analysis for H&R Block. The strong third quarter update, outlook upgrade and dividend affirmation have come after a weaker start to the year, with the share price still down about 15% year to date despite a 21% 30 day share price gain and a much stronger 3 and 5 year total...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

Assessing Casey’s General Stores (CASY) Valuation As Southern Expansion Into Alabama And Florida Accelerates

Casey's General Stores (CASY) is pushing deeper into the US South with new stores in Alabama and Florida, including converted former CEFCO locations, putting its pizza focused convenience model up against established regional chains. See our latest analysis for Casey's General Stores. These southern store openings come as investor enthusiasm is already strong, with the share price at US$877.07 and a 30 day share price return of 18.82% contributing to a 1 year total shareholder return of...
NYSE:FLR
NYSE:FLRConstruction

A Look At Fluor (FLR) Valuation After Earnings Miss And Tightened 2026 EBITDA Guidance

Fluor (FLR) just released first quarter 2026 results that fell short of analyst expectations, after higher project costs and geopolitical delays pressured earnings and led management to narrow its full year adjusted EBITDA guidance. See our latest analysis for Fluor. The stock reacted sharply to the earnings miss and tightened guidance, with a 7 day share price return that declined 16.77% and a 30 day share price return that declined 11.22%, although the 1 year total shareholder return of...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Assessing Oruka Therapeutics (ORKA) Valuation After Equity Raise Collaboration Deal And Trial Updates

Oruka Therapeutics (ORKA) stock is drawing attention after a recently completed $700 million common stock offering raised dilution concerns and coincided with volatility around its Halozyme Hypercon collaboration and interim clinical trial updates. See our latest analysis for Oruka Therapeutics. At a latest share price of US$65.68, Oruka’s recent common stock offering, Halozyme Hypercon agreement and interim trial readouts have gone hand in hand with sharp swings, including a 99.76% 3 month...
NasdaqCM:OSW
NasdaqCM:OSWConsumer Services

A Look At OneSpaWorld Holdings (OSW) Valuation After Upbeat Q1 Results And Raised Guidance

OneSpaWorld Holdings (OSW) has drawn fresh attention after reporting first quarter earnings, with revenue of US$247.63 million and net income of US$21.33 million, and raising full year revenue guidance. See our latest analysis for OneSpaWorld Holdings. The 1-year total shareholder return of 24.31% and 3-year total shareholder return of 105.87% point to strong long term wealth creation. Meanwhile, the year to date share price return of 16.23% suggests momentum has been building despite a...
NasdaqGS:BIDU
NasdaqGS:BIDUInteractive Media and Services

Baidu (NasdaqGS:BIDU) Valuation Check As Kunlunxin Chip Unit IPO Plans Come Into Focus

Baidu’s chip unit IPO plans put Kunlunxin in the spotlight Baidu (NasdaqGS:BIDU) is moving ahead with an IPO for its Kunlunxin chip subsidiary on Shanghai’s STAR Board, while also preparing for a potential Hong Kong listing. This could reshape how investors view its AI chip operations. See our latest analysis for Baidu. The Kunlunxin IPO plans land at a time when Baidu’s short term momentum is strong, with a 34.47% 1 month share price return and a 59.72% 1 year total shareholder return,...
NasdaqGS:INBX
NasdaqGS:INBXBiotechs

Should Positive INBRX-106 Phase 2 Combo Data in Head and Neck Cancer Require Action From Inhibrx Biosciences (INBX) Investors?

Inhibrx Biosciences recently reported positive interim Phase 2 data from the HexAgon study, where its hexavalent OX40 agonist INBRX-106 combined with pembrolizumab produced higher confirmed response rates and more complete responses than pembrolizumab alone in first-line PD-L1 high head and neck cancer patients. These data, supported by strong T-cell activation signals and a generally manageable safety profile, have prompted plans for a Phase 3 trial and broader exploration of INBRX-106...